AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06635005 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06635005 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: Receive the Low-EDIH dietary pattern intervention
Study NCT04896723 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Sexual function questionnaire
Description: Sexual function questionnaire and cognitive screening assessments
Study NCT06635005 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical Device Usage and Evaluation
Description: Wear an activity tracker
Study NCT06635005 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: Undergo motivational interviews
Study NCT06635005 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional Assessment
Description: Participate in nutrition counseling
Study NCT06635005 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06634654 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total Knee Arthroplasty
Description: Total Knee Arthroplasty is performed using conventional surgical techniques.
Study NCT06634654 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Multifaceted diagnostic assessments
Description: Multifaceted diagnostic assessments involving genetic analysis, biomechanical data collection, radiographic imaging, and psychological evaluations.
Study NCT06634654 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Follow-ups
Description: Postoperative follow-up includes behavioral interventions, such as lifestyle counseling and rehabilitation programs, tailored based on AI-driven insights into individual patient recovery profiles.
Study NCT06634654 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Genetic screening
Description: Genetic screening and analysis, including whole exome sequencing, are conducted to identify genetic markers that might influence the outcomes of knee arthroplasty. This data is utilized within AI models to predict patient-specific surgical outcomes and recovery processes.
Study NCT06001398 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Acceptance and Commitment Therapy (PACT)
Description: PACT is a 2-session intervention based on the Focused Acceptance and Commitment Therapy treatment literature
Study NCT06001398 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The content of the control intervention covers a range of nutrition and healthy lifestyle topics including USDA's MyPlate
Study NCT06701305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efinopegdutide
Description: Subcutaneous injectable solution
Study NCT06701305 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subcutaneous injectable solution
Study NCT06701305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Oral solution
Study NCT06701305 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Acetaminophen
Description: Oral solution
Study NCT06701942 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multiple family group intervention therapy
Description: Overview The intervention will be implemented at designated clinics where adolescents living with HIV/AIDS (ALHIV) and their families currently receive care. These sites will provide the MFG intervention alongside standard care services. All eligible adolescents and their family members who consent to participate will be included in the intervention group.~Program Structure The MFG intervention consists of 16 structured sessions, each running for 90 minutes. Sessions will be scheduled to coincide with clinic days over a 14-week period to maximize accessibility and attendance. Parent peers and community health workers, trained by the research team, will facilitate these group sessions.~Session Format Sessions on the MFGT will begin with introducing participants to one another, the facilitators, and the program curriculum. Subsequent sessions will concentrate on areas such as respectful communication, support, resilience building, problem-solving, conflict resolution, stress management
Study NCT05860712 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Irrigation
Description: Cinnamon to be prepared were mixed with 50% ethanol and this suspension was placed on the magnetic stirrer for 4 hours.Whitman's filter paper was used to obtain the filtrate which was then dried to obtain the extract. The extract was dried to evaporate the solvent to prevent the influence of extracting agent (ethanol) on the final extract. Cinnamon extract was obtained using cinnamon bark which was pulverized into medium coarse granules. The extracting agent and the procedure to obtain the final extract.These extracts were stored in dark coloured bottles at 4 degree Celsius until use.
Study NCT05860712 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Irrigation
Description: Cinnamon to be prepared were mixed with 50% ethanol and this suspension was placed on the magnetic stirrer for 4 hours.Whitman's filter paper was used to obtain the filtrate which was then dried to obtain the extract. The extract was dried to evaporate the solvent to prevent the influence of extracting agent (ethanol) on the final extract. Cinnamon extract was obtained using cinnamon bark which was pulverized into medium coarse granules. The extracting agent and the procedure to obtain the final extract.These extracts were stored in dark coloured bottles at 4 degree Celsius until use.
Study NCT05788237 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RSVpreF+qIRV
Description: RSVpreF containing 2 stabilized RSV prefusion F antigens, in equal amounts from virus subgroups A and B combined with Quadrivalent influenza modRNA vaccine (qIRV) encoding HA of 4 strains as recommended for the influenza season (2 A strains, 2 B strains)
Study NCT05788237 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: qIRV
Description: Quadrivalent influenza modRNA vaccine (qIRV) encoding HA of 4 strains as recommended for the influenza season (2 A strains, 2 B strains)
Study NCT05788237 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RSVpreF
Description: RSVpreF containing 2 stabilized RSV prefusion F antigens, in equal amounts from virus subgroups A and B
Study NCT05788237 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.9% saline for injection
Study NCT05788237 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RSVpreF + qIRV 1.0 mL formulation
Description: RSVpreF containing 2 Stabilized RSV prefusion F antigens, in equal amounts from virus subgroups A and B plus qIRV Encoding HA of 4 strains as recommended for the influenza season (2 A strains and 2 B strains) plus sterile water as diluent for injection
Study NCT05788237 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RSVpreF + qIRV 0.5 mL formulation
Description: RSVpreF containing 2 Stabilized RSV prefusion F antigens, in equal amounts from virus subgroups A and B plus qIRV Encoding HA of 4 strains as recommended for the influenza season (2 A strains and 2 B strains)
Study NCT06384365 — intervention group
Intervention type: BEHAVIORAL
Intervention: Physical activity
Description: The control and the athletic group differ in the degree of physical acitvity
Study NCT05013749 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hysterectomy
Description: Hysterectomy: An incision will be made above the level of the placenta, delivering the newborn. Uterotonics will be administered, and spontaneous delivery of the placenta will be awaited using gentle traction. The absence of spontaneous separation of the placenta will confirm the diagnosis of PAS, the patient will undergo to hysterectomy. The complete removal of the uterus will be attempted, including the cervix, the duration of the intervention and intraoperative blood loss will be recorded, as well as the damage to organs neighboring the uterus. In this arm of the study, to hysterectomy will be performed in 100% of patients
Study NCT05013749 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Partial Myometrial Resection
Description: Partial myometrial resection: The technique described by Palacios-Jaraquemada et al5. will be followed. Briefly, the uterus will be dissected to free it from the posterior wall of the bladder to the cervix. The vesico-uterine vessels will be ligated and the parametrial space will be visualized. The hysterotomy will be performed in the upper segment, immediately above the area of invasion of the myometrium. The entire invaded myometrium and the entire placenta will be removed. The uterus will repair itself in one or two layers. Intrauterine balloon tamponade will be used if indicated.
Study NCT06419803 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin
Description: Insulin will be used in gestational diabetics to control blood glucose levels
Study NCT05698524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCI 24781
Description: Patients will take the PCI-24781/Abexinostat on days 1-4, 8-11, 15-18, and 22-25 of each 28-day cycle.
Study NCT05698524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Patients will receive temozolomide at a dose of 50 mg/mg2, taken by mouth once daily.
Study NCT06580184 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LEARN 2 Platform
Description: The LEARN 2 Platform will provide tailored prevention education of HIV-comorbidities with shared risk factors. Participants will navigate LEARN 2 and access targeted health content.
Study NCT06580184 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: LEARN 2 Platform
Description: The LEARN 2 Platform will provide tailored prevention education of HIV-comorbidities with shared risk factors. Participants will navigate LEARN 2 and access targeted health content.
Study NCT05657873 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: L-SABR
Description: L-SABR will be delivered in a week during which the patient receives no chemotherapy. L-SABR can be on the same week or even day as anti-PD-(L)1 therapy.
Study NCT05657873 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Anti-PD-(L)1 based immunotherapy
Description: Standard of care treatment (anti-PD-(L)1 based immunotherapy +/- platinum based chemotherapy
Study NCT05657873 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-PD-(L)1 based immunotherapy
Description: Standard of care treatment (anti-PD-(L)1 based immunotherapy +/- platinum based chemotherapy
Study NCT05657873 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Platinum based chemotherapy
Description: Standard of care treatment (anti-PD-(L)1 based immunotherapy +/- platinum based chemotherapy
Study NCT05657873 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum based chemotherapy
Description: Standard of care treatment (anti-PD-(L)1 based immunotherapy +/- platinum based chemotherapy
Study NCT05795062 — intervention group
Intervention type: DRUG
Intervention: apixaban
Description: patients treated with apixaban
Study NCT05795062 — intervention group
Intervention type: DRUG
Intervention: warfarin
Description: patients treated with warfarin
Study NCT05338437 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Description: Bilateral quadriceps muscle stimulation
Study NCT04938063 — intervention group
Intervention type: OTHER
Intervention: Assessing the correlation between Functional Impairment and Parenting Stress
Description: Association Between Functional Impairment and Parenting Stress Among Children Diagnosed With Diplegic Cerebral Palsy
Study NCT06107959 — intervention group
Intervention type: OTHER
Intervention: Pre-surgical nutrition, hydration, RMR, and body composition assessments
Description: Urine sample, InBody device platform, Metabolic cart with hood to collect RMR.
Study NCT06107959 — intervention group
Intervention type: OTHER
Intervention: Post-surgical nutrition, hydration, RMR and body composition assessments
Description: Same as pre-surgical tests at 1 week, 3 weeks, 6 weeks, and 12 weeks follow up time points.
Study NCT06566495 — intervention group
Intervention type: DEVICE
Intervention: collection of microbiological material from reusable tourniquets
Description: Microbiological analysis~The material was collected in each group in the same way.
Study NCT06564337 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surveyed zirconia crown
Description: Patient recruitment will be from the patient population that presents to the undergraduate dental clinic requiring removable dental prosthesis (RPD) to replace missing teeth. Selection of abutment teeth for zirconia surveyed crowns will be similar to that currently utilized when selecting RPD abutments to be restored with either porcelain fused to metal or full metal surveyed crowns for tissue and tooth supported RPD's.
Study NCT06542003 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Movin' and Groovin' for Wellness
Description: Movin' and Groovin' for Wellness (MGW) is a 10-week program consisting of facilitated drumming and dancing sessions. The sessions include guided activities involving drumming, dancing, and group improvisation. Each session lasts approximately 1.5 hours, with activities designed to improve mental well-being, enhance social connections, and foster creative expression. The sessions are guided by professional facilitators.
Study NCT04760574 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Testosterone
Description: Serum total testosterone and free testosterone level
Study NCT06338800 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: One session exposure with Virtual Reality
Description: Participants will receive one session exposure with virtual reality from their therapists.
Study NCT04994366 — intervention group
Intervention type: OTHER
Intervention: Thank you card
Description: A card thanking the patient for choosing NYU and entrusting us with their care. The card notifies the patient that they may receive a patient satisfaction survey after discharge.
Study NCT04651218 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exericse
Description: participants perform aerobic exercise until they expend 500 kcal
Study NCT06413589 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SMOF lipid 20%
Description: Drug: SMOF lipid 20% SMOF 20%, a blend of soybean oil, medium-chain triglycerides, olive oil, and fish oil, is a new lipid emulsion product that was provided as a bolus dose of 1.5ml/kg for one hour, followed by a maintenance dose of 6 ml/kg for a period of four hours to the active comparator group
Study NCT06413589 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: standard treatment for clozapine toxicity
Description: Hypotension was initially treated with isotonic crystalloid; vasopressors were utilised if intravenous fluids failed to restore the hypotension. This was in the form of norepinephrine with a dose of 0.05 μg/kg/min and titrated till reaching the goal mean arterial pressure (>65 mmHg) \[29\].~Those experiencing seizures due to CBZ overdose were treated with benzodiazepines (diazepam) at a dose of 10-20 mg. Benzodiazepines are considered allosteric modulators of the gamma-aminobutyric acid channel.~MDAC (50 grammes every six hours) was given to all patients in the current study. Those with severe poisoning were given the MDAC after securing the airway with a cuffed endotracheal tube
Study NCT05340517 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: video-assisted rib planting
Description: Give the patient intercostal nerve block and laryngeal mask anesthesia, after that, put the patient in lateral position. Make a 4-6cm posterolateral incision along the lower edge of the scapula，sever latissimus dorsi and serratus anterior and reach the rib surface. Lift the scapula with the abdominal retractor (or xiphoid retractor), Free adhesion tissue inside the scapula and put in the thoracoscopic lens. Free the tissue of the upper and lower edges of the ribs carefully, reset ribs and insert rib plate, which is fixed by 90° electric drill and locking screw.
Study NCT05013892 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: NTS-WBRT (normal tissue sparing whole brain radiation therapy)
Description: Radiation
Study NCT05013892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Memantine
Description: Capsule, taken orally
Study NCT04719585 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine vs. Opioid
Description: Prior to discharge, the drug is prescribed for a total of 6 weeks by dividing the duloxetine-administered group and the opioid-administering group, respectively. The administration period of duloxetine or opioid is 6 weeks. The follow-up periods for out-patient clinic are 2 weeks, 6 weeks, 3 months, 6 months, and 1 year after the TKA surgery. During the follow-up period, NSAIDs will be prescribed the same in both groups. As an additional rescue medication, 650 mg of acetaminophen will be allowed to use up to 2g per day.
Study NCT04719585 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duloxetine vs. Opioid
Description: Prior to discharge, the drug is prescribed for a total of 6 weeks by dividing the duloxetine-administered group and the opioid-administering group, respectively. The administration period of duloxetine or opioid is 6 weeks. The follow-up periods for out-patient clinic are 2 weeks, 6 weeks, 3 months, 6 months, and 1 year after the TKA surgery. During the follow-up period, NSAIDs will be prescribed the same in both groups. As an additional rescue medication, 650 mg of acetaminophen will be allowed to use up to 2g per day.
Study NCT06234345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg
Description: Participants randomized to this group will receive 1 capsule per inhalation twice a day
Study NCT06234345 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Comparator - Trimbow®
Description: Participants randomized to this group will receive 2 triggering twice a day
Study NCT06535126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CanProFem-AK
Description: Dosage form - vaginal suppositories (100 mg). Dosage regimen - single intravaginal administration of suppository. Vaginal suppositories are inserted as deeply as possible while the participant is lying down; the participant must remain in a horizontal position for 45 minutes after the administration. The total duration of volunteer participation in the study is one day. Medical observation (including gynaecological monitoring with vaginal bacterial swab test) of the subject condition after the drug administration will be carried out after 3, 6, 9, 12 and 24 hours. Repeated laboratory blood and urine tests will be performed after 24 hours. Participants of the study will be closely monitored for 24 hours after the initial administration of the drug to detect any immediate adverse events. If the subject experiences an immediate adverse event, appropriate treatment will be provided.
Study NCT05015894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480-0389
Description: A single dose of 18 mg NNC0480 0389 administered subcutaneously (under the skin).~Total duration of study participation for each participant is 38 to 66 days
Study NCT05548790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Spielberger State Anxiety Inventory (STAI-S)
Description: STAI is one of the most frequently used scales in anxiety research, although it is not a specific scale for dental anxiety
Study NCT05548790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dental Fear Scale (DFS)
Description: DFS is a scale developed by Kleinknecht used to determine dental fear in different dimensions. This is a Likert-type scale with a score of 1-5. It has 20 items. It examines the level of fear in terms of dentist avoidance, somatic symptoms of fear, and fear of various applications in dentistry practice
Study NCT05548790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified Dental Anxiety Scale (MDAS)
Description: MDAS was developed by Humphris et al. by adding a question related to injection. The scale consists of five-point Likert-type rating with five options. The scoring in this scale varies between 5 and 25
Study NCT05548790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visual Analog Scale (VAS)
Description: VAS is ideal for evaluating situations that cannot be measured using digital and oral information. In the present study, a scale comprising 100-mm closed-end line was used to measure the anxiety level. One end of the scale was labeled as no anxiety and the other end as maximum anxiety imaginable
Study NCT05492136 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Additional margin coagulation
Description: After performing the hepatectomy the selected device should be applied onto the surgical margin following the protocol 3-4 s/cm2 of liver transection surface at maximum power output in order to perform an additional margin coagulation
Study NCT06381479 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: probiotics
Description: each capsule contains Lactiplantibacillus plantarum and Lacticaseibacillus paracasei, 2 caps daily use
Study NCT06381479 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: The placebo capsule contains microcrystalline cellulose, 2 caps daily use.